TRVI
Trevi Therapeutics, Inc.NASDAQHealthcare$11.94+3.11%ClosedMarket Cap: $1.53B
As of 2026-04-06
Insider Statistics (Q1 2026)
Purchases
6
Sales
0
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri Feb 20 | Cassella James V | officer: Chief Development Officer | Sell | 215,000 | $10.56 | 215,000 |
| Fri Feb 20 | Galletta Christopher | officer: See Remarks | Sell | 35,000 | $10.56 | 35,000 |
| Fri Feb 20 | SCIASCIA THOMAS | officer: Chief Scientific Officer | Sell | 85,000 | $10.56 | 85,000 |
| Fri Feb 20 | GOOD JENNIFER L | director, officer: President & CEO | Sell | 675,000 | $10.56 | 675,000 |
| Fri Feb 20 | Simon Farrell | officer: Chief Commercial Officer | Sell | 160,000 | $10.56 | 160,000 |
| Fri Feb 13 | SANDELL SCOTT D | 10 percent owner | Sell | 0 | $0.00 | 948,948 |
| Fri Feb 13 | Florence Anthony A. Jr. | 10 percent owner | Sell | 0 | $0.00 | 948,948 |
| Fri Feb 13 | Florence Anthony A. Jr. | 10 percent owner | Sell | 1,851,852 | $1.37 | 0 |
| Fri Feb 13 | SANDELL SCOTT D | 10 percent owner | Sell | 1,851,852 | $1.37 | 0 |
| Fri Feb 13 | Behbahani Ali | 10 percent owner | Sell | 0 | $0.00 | 948,948 |